Efficacy and mechanisms of neuromodulation in the treatment of irritable bowel syndrome
Abstract Disorders of gut-brain interaction (DGBI), including irritable bowel syndrome (IBS), have a significant impact on patients, reducing their quality of life and work efficiency. Pharmacological therapy is primarily used as a frontline treatment option for treating IBS. However, owing to the h...
| Published in: | Bioelectronic Medicine |
|---|---|
| Main Authors: | , , , , |
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-09-01
|
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s42234-025-00186-5 |
